KKR gets the top award for its exit of CHI Overhead Doors, and for its forward-looking employee ownership view. Our winners for best deals of 2022 are in six categories.

Deals of the Year

Building garage doors isn’t the sexiest vocation on earth, unless you work for a company that makes them and then rewards you with more money than you’ve ever seen before. That’s exactly what happened when KKR exited its investment with portfolio company CHI Overhead Doors, and it’s one of the reasons why we’re crowning that transaction as overall Deal of the Year, leading off our annual awards issue, which crowns private equity firms for the best exits made in 2022.

In addition to the overall Deal of the Year, we salute winners in these categories. They are: Large Market, for Greenbriar’s exit of Radwell International, a specialist in industrial components; Mid-Market, for Francisco’s creation from scratch of Trellis Rx; Small Market, for Blackford Capital’s exit of Quality Aluminum Products; International, for JC Flowers’ rejuvenation of Interactive Investor; and Secondaries, for KKR’s work with Internet Brands (yes, KKR gets two trophies this year – the rich get richer).


Deal of the Year: KKR’s exit of CHI Overhead Doors

KKR does well by doing good as it shares the wealth with workers and CHI as part of its employee ownership program.

Large Market Deal of the Year: Greenbriar and Radwell International

Greenbriar put a shine on Radwell, a refurbisher of industrial automation components.

International Deal of the Year: JC Flowers and Interactive Investor

Tech upgrades and acquisitions rejuvenated retail investing platform Interactive Investor.

Secondaries Deal of the Year: KKR and Internet Brands

KKR pulled a rabbit out of a hat in its syndication of Internet Brands during a brutal market climate.

Small Market Deal of the Year: Blackford Capital and Quality Aluminum Products

Quality Aluminum Products was showing signs of rust until Blackford came knocking.

Mid-Market Deal of the Year: Francisco Partners and Trellis Rx

Francisco Partners founded – yes, founded – a specialty pharmacist to solve a problem with no existing cure at the time.




Copyright PEI Media

Not for publication, email or dissemination